CN Patent

CN101208094B — 药代动力学改善的化合物

Assigned to Surface Logix Inc · Expires 2014-10-15 · 12y expired

What this patent protects

本发明涉及ROCK1及ROCK2的抑制剂以及这种化合物的药代动力学和/或药效动力学性质的调节方法。本发明还提供可用于治疗疾病的ROCK1和/或ROCK2抑制方法。

USPTO Abstract

本发明涉及ROCK1及ROCK2的抑制剂以及这种化合物的药代动力学和/或药效动力学性质的调节方法。本发明还提供可用于治疗疾病的ROCK1和/或ROCK2抑制方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101208094B
Jurisdiction
CN
Classification
—
Expires
2014-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Surface Logix Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.